IP Library Granted Patent US 9,629,997
Granted Patent B2
US 9,629,997 · App. 14/036,405 · Granted Apr 25, 2017

Materials and methods for protecting against neuromas

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,629,997
App. No.
14/036,405
Granted
Apr 25, 2017
Kind
B2
Abstract

The subject invention provides devices and methods for alleviating discomfort associated with neuroma formation. The devices and methods of the invention effectively use the body's natural response of reconstructing implanted biomaterials to minimize the size of, isolate, and protect a neuroma. In preferred embodiments, the subject device is a cylindrical cap, wherein the internal chamber of the cylindrical cap physically partitions the nerve to enable an arrangement of nerve fibers (as opposed to haphazardly arranged nerve fibers often produced in neuromas). In addition, the cap's material remodels into a tissue cushion after implantation, which protects the neuroma from being stimulated and inducing pain.

Claims (9)

1. A sterile device for protecting against a neuroma forming at a stump of a transected nerve, wherein the device comprises:

a body having an open proximal end and, integrally formed with the body, a closed distal end wherein the body of the device is less than 100 mm in diameter and less than 500 mm in length;

wherein the body, including the closed distal end, defines an internal chamber, without openings other than at the proximal end, thereby inhibiting axonal escape from the device when the device is implanted on the nerve stump by inserting the nerve stump through the opening in the proximal end; and

one or more separators within the internal chamber that divide the internal chamber thereby creating a plurality of separate volumes into which regenerating axons grow such that one or more regenerating axons are physically separated from one or more other regenerating axons;

and wherein the device comprises a biomaterial that remodels into a tissue cushion after implantation.

2. The device according to claim 1 , wherein the device comprises a biomaterial selected from the group consisting of: high density polyethylene (HDPE), polyethylene glycol (PEG) hydrogel, and purified proteins from human or sources.

3. The device according to claim 1 , wherein the device comprises a biomaterial selected from the group consisting of small intestine submucosa (SIS), amnion, dermis, collagen and decellularized fascia.

4. The device according to claim 1 , wherein the body is cylindrical in shape.

5. A method for protecting against neuromas comprising: inserting and securing a nerve stump into a device of claim 1 .

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded May 31, 2018
From: MIDCAP FUNDING IV TRUST; MIDCAP FINANCIAL TRUST
To: AXOGEN CORPORATION; AXOGEN, INC. FORMERLY KNOWN AS LECTEC CORPORATION
Reel/Frame 045952/0283 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2017
From: AXOGEN, INC.
To: AXOGEN CORPORATION
Reel/Frame 041608/0352 →
SECURITY INTEREST Recorded Nov 1, 2016
From: AXOGEN, INC. FORMERLY KNOWN AS LECTEC CORPORATION; AXOGEN CORPORATION
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 040189/0049 →
SECURITY INTEREST Recorded Nov 1, 2016
From: AXOGEN, INC. FORMERLY KNOWN AS LECTEC CORPORATION; AXOGEN CORPORATION
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 040189/0429 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2014
From: DEISTER, CURT; SIMON, CRYSTAL
To: AXOGEN, INC.
Reel/Frame 033545/0138 →